CD200 and head and neck squamous cell carcinoma: As the metastatic HNSCC exhibited significantly higher CD200 expression compared to the non-metastatic one, (Supplementary Figure S1), here, we analyzed the genomic landscape associated with CD200 expression in the clinical dataset of HNSCC.